| Mutant P53 in the formation and progression of the tumor microenvironment: friend or foe ER Asl, D Rostamzadeh, PHG Duijf, S Mafi, B Mansoori, S Barati, WC Cho, ... Life sciences 315, 121361, 2023 | 16 | 2023 |
| The role of microRNAs in multidrug resistance of glioblastoma P Mahinfar, B Mansoori, D Rostamzadeh, B Baradaran, WC Cho, ... Cancers 14 (13), 3217, 2022 | 14 | 2022 |
| MicroRNAs in the cancer cell-to-cell communication: An insight into biological vehicles B Mansoori, B Baradaran, A Nazari, FA Gaballu, WCS Cho, B Mansoori Biomedicine & Pharmacotherapy 153, 113449, 2022 | 12 | 2022 |
| The synergy between miR-486–5p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells B Mansoori, S Najafi, A Mohammadi, H AsadollahSeraj, P Savadi, ... Biomedicine & Pharmacotherapy 141, 111925, 2021 | 7 | 2021 |
| MicroRNA-143-5p suppresses ER-positive breast cancer development by targeting oncogenic HMGA2 B Mansoori, S Kiani, AA Mezajin, P Zandi, H Banaie, D Rostamzadeh, ... Clinical Breast Cancer 23 (7), e480-e490. e3, 2023 | 3 | 2023 |
| Metabolic pathways in breast cancer reprograming: an insight to non-coding RNAs F Abedi-Gaballu, E Kamal Kazemi, SA Salehzadeh, B Mansoori, F Eslami, ... Cells 11 (19), 2973, 2022 | 2 | 2022 |
Behzad MansooriThe Wistar Institute, Cellular and molecular oncogenesis Program, Philadelphia, PA, USA在 wistar.org 的电子邮件经过验证
